promising biomarkers in ms: serum nfl & gfap
Published 2 years ago • 225 plays • Length 0:42Download video MP4
Download video MP3
Similar videos
-
2:01
emerging biomarkers in ms: the value of serum nfl
-
4:13
emerging biomarkers in ms: cntn1 and gfap
-
3:31
gfap and nfl as biomarkers in nmosd
-
2:29
serum nfl: a first-in-class biomarker paving the way towards precision medicine in ms
-
1:31
gfap: a potential biomarker for progression in ms
-
4:48
serum neurofilament light chain levels as a biomarker in ms
-
2:59
the development of clinically useful biomarkers in ms
-
2:14
prognostic biomarkers in multiple sclerosis
-
3:33
remyelinating treatments under investigation in ms
-
7:49
what dictates ms progression: pira vs relapses
-
30:55
functional analysis of human microbiome, metagenomes, metatranscriptomics... - curtis huttenhower
-
1:30
developments in biomarkers for ms susceptibility and prodrome
-
3:14
sgfap as a biomarker in nmosd
-
4:59
serum biomarkers of brain atrophy in ms
-
0:31
new biomarker in ms?
-
3:26
nfl to monitor treatment effects in ms
-
3:55
exploring the predictive value of gfap in progressive ms
-
4:28
novel biomarkers to predict progression in ms
-
2:00
oct measures association with serum/csf biomarkers in cis patients
-
4:41
interpretation of serum nfl depends on the selection of a reference population
-
3:10
biomarkers of disease activity and treatment response in ms
-
6:04
the salivary microbiome as a diagnostic biomarker in ms